Novartis Ag (NVS) Invested Capital (2009 - 2026)

Novartis Ag (NVS) has 13 years of Invested Capital data on file, last reported at -$19.0 million in Q1 2026.

• Quarterly Invested Capital changed N/A year-over-year to -$19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 billion (up 10.01% YoY) and the FY2025 annual result came in at $46.4 billion, up 3.99% from the prior year.
• Invested Capital retreated to -$19.0 million in Q1 2026 per NVS's latest filing, from $46.4 billion in the prior quarter.
• The five-year high for Invested Capital was $90.7 billion in Q4 2022, with the low at -$1.1 billion in Q2 2022.
• Average Invested Capital over 5 years is $25.2 billion, with a median of $8.3 billion recorded in 2023.
• Year-over-year, Invested Capital tumbled 111.85% in 2022 and surged 871.07% in 2023.
• Novartis Ag's Invested Capital stood at $90.7 billion in 2022, then plunged by 47.76% to $47.4 billion in 2023, then dropped by 5.75% to $44.6 billion in 2024, then advanced by 3.99% to $46.4 billion in 2025, then plunged by 100.04% to -$19.0 million in 2026.
• Business Quant data shows NVS's Invested Capital at -$19.0 million in Q1 2026, $46.4 billion in Q4 2025, and -$9.0 million in Q3 2025.